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The mechanisms that generate itch are poorly understood at both
the molecular and cellular levels despite its clinical importance. To
explore the peripheral neuronal mechanisms underlying itch, we
assessed the behavioral responses (scratching) produced by s.c.
injection of various pruritogens in PLC3- or TRPV1-deficient mice.
We provide evidence that at least 3 different molecular pathways
contribute to the transduction of itch responses to different pru-
ritogens: 1) histamine requires the function of both PLC3 and the
TRPV1 channel; 2) serotonin, or a selective agonist, -methyl-
serotonin (-Me-5-HT), requires the presence of PLC3 but not
TRPV1, and 3) endothelin-1 (ET-1) does not require either PLC3 or
TRPV1. To determine whether the activity of these molecules is
represented in a particular subpopulation of sensory neurons, we
examined the behavioral consequences of selectively eliminating 2
nonoverlapping subsets of nociceptors. The genetic ablation of
MrgprD neurons that represent 90% of cutaneous nonpepti-
dergic neurons did not affect the scratching responses to a number
of pruritogens. In contrast, chemical ablation of the central branch
of TRPV1 nociceptors led to a significant behavioral deficit for
pruritogens, including -Me-5-HT and ET-1, that is, the TRPV1-
expressing nociceptor was required, whether or not TRPV1 itself
was essential. Thus, TRPV1 neurons are equipped with multiple
signaling mechanisms that respond to different pruritogens. Some
of these require TRPV1 function; others use alternate signal trans-
duction pathways.
itch  PLCb3  scratching
I tch can be induced by a variety of chemical stimuli generatedwithin or applied to the skin, and this reliably produces a
characteristic scratching reflex (1). It is significant that in
humans, itch is never felt in muscle, joints, or internal organs (2).
In contrast, itch is readily evoked from skin, which is innervated
by primary afferents that respond directly to itch-producing
stimuli, or are activated indirectly, via keratinocytes, mast cells,
and Langerhans cells, which release itch-producing compounds.,
Schmelz and colleagues (3) used iontophoresis of histamine to
show that the unmyelinated fibers that convey information
producing histamine-evoked itch comprise 5% of the afferent
C-fibers in human skin. Based on conduction velocities, re-
sponses to sensory modalities (heat vs. mechanical stimuli) and
innervation territories, these histamine-sensitive fibers appear to
be distinct from the polymodal C-fiber nociceptors that mediate
pain (3, 4).
These findings are the basis of the specificity theory of itch,
which posits that itch is transmitted by neurons distinct from
those that transmit pain. In fact, electrophysiological studies of
spinothalamic tract (STT) neurons in the cat have provided
evidence for the existence of specific itch neurons in the central
nervous system (5). Other reports (6, 7), however, found that
histamine-responsive STT neurons were also activated by both
noxious mechanical and heat stimuli. Histamine-sensitive pri-
mary afferents in human also respond to capsaicin, a painful
stimulus (4). These results argue against the specificity theory.
However, a gastrin-releasing peptide receptor (GRPR) ex-
pressed in the spinal dorsal horn has been specifically implicated
in itch, but not pain (8). Clearly, the extent to which itch is
exclusively mediated by specific, nonnociceptive neurons re-
mains controversial.
A major difficulty in discerning the extent to which the
specificity view holds for the generation of itch is the lack of
molecular markers of pruritogen-responsive afferents or of
itch-specific genes that distinguish itch-related dorsal root gan-
glion (DRG) neurons from others. Recently, we found that
histamine induces itch responses (scratching) via the action of a
histamine H1 receptor that is expressed by a small subset of
C-fibers. We also showed that intracellular signal transduction
via PLC3 is critical to the histamine-induced scratching in mice
(9). Other studies reported that TRPV1-deficient mice also
showed diminished scratching to histamine or trypsin (10, 11).
Taken together, these results suggest that TRPV1PLC3
neurons are histamine-responsive itch neurons.
The TRPV1 channel is directly activated by pain-producing
stimuli such as capsaicin, heat and acid but not by pruritogens.
Activation of TRPV1 neurons by pruritogens appears, instead,
to require an intracellular signal-transducingmechanism that lies
downstream of G protein-coupled receptors (10, 11). Given that
a number of different pruritogens can trigger distinct and
specific intracellular signaling pathways to activate itch-sensing
neurons, it is possible that there are different subsets of TRPV1-
expressing neurons specialized to process signals from specific
groups of pruritogens. Alternatively, each of the TRPV1-
expressing neurons may be equipped with multiple mechanisms
to process responses to different pruritogens and to generate an
itch response. One approach to assessing these different possi-
bilities is to ablate the DRG neurons that express TRPV1 and to
examine the behavioral consequences of applying different
groups of pruritogens that may signal through different mech-
anisms. Using this approach, we now report that TRPV1
neurons, as a population, respond to pruritogens through mul-
tiple and distinct intracellular mechanisms.
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Results
Behavioral Responses to Innocuous or Noxious Thermal, Mechanical
Stimuli Are Normal in PLC3-Deficient Mice. Many of the prurito-
genic stimuli that produce scratching can also produce behaviors
indicative of pain. In fact, our previous finding that the PLC3
protein is predominantly expressed in C-fiber nociceptors (9)
raised the possibility that PLC3 is part of a signaling pathway
that contributes to noxious stimulus-evoked pain behavior. We
specifically addressed this question by studying the contribution
of PLC3 in a variety of assays of pain behavior (Fig. 1). In the
hot plate and Hargreaves tests, the paw is stimulated by contact
with a hot plate or radiant heat source, respectively, and the time
to paw licking or withdrawal is measured. In the tail immersion
test, the distal portion of the tail is immersed in a hot or cold
water bath, and the time to tail f lick is recorded. PLC3-mutant
mice were indistinguishable from their wild-type littermates in
the hot plate (48, 52.5, and 55 °C), Hargreaves, and tail immer-
sion (46 °C and 4 °C) tests (Fig. 1 A, B, and E). Thus, acute
noxious heat or cold responsiveness is intact in the absence of
PLC3.
C-fiber nociceptors have also been implicated in sensitivity to
innocuous temperature (12–14). We therefore also asked
whether PLC3-deficient mice could discriminate between 2
innocuous temperatures (30 vs. 40 °C). Mice were placed in an
apparatus in which 2 chambers were maintained at different
temperatures. We allowed the mice free access to the 2 chambers
and measured the time spent at the different temperatures. Fig.
1C illustrates that both wild-type and PLC3-mutant mice
equally favor the 30 °C chamber, spending 80% of their time
at this temperature. Finally, we tested mice for mechanical
sensitivity. The mechanical withdrawal threshold in the PLC3-
mutant mice, tested with calibrated von Frey filaments, did not
differ from wild-type mice (Fig. 1D). These results indicate that
the appreciation of both innocuous and noxious temperature and
the ability to perceive noxious mechanical stimuli are preserved
in the absence of PLC3.
We also did not find any differences in the magnitude of the
thermal hypersensitivity that occurs in the setting of inflamma-
tion of the hindpaw produced by injection of Complete Freund’s
Adjuvant (CFA) (Fig. 1E). Importantly, the magnitude of paw
edema produced by CFA did not differ in PLC3-deficient mice
when compared with their wild-type littermates (Fig. 1F), which
indicates that the afferent terminals are capable of generating a
normal neurogenic inflammatory response in the absence of
PLC3.
Next, we examined the mice in the formalin test, which is
considered to model tissue-injury induced postoperative pain.
We monitored the flinching and licking behavioral responses
produced by hindpaw injection of formalin and again, we did not
find significant differences between wild-type and mutant mice,
in either the first (0–10 min) or in the second phase (10–60 min)
of the test (Fig. 1G). Taken together, these data suggest that
PLC3 is not required for the normal appreciation of innocuous
or noxious mechanical or thermal stimuli, both in the absence
and presence of tissue injury/inflammation. Based on these
observations, we believe that any changes in scratching behavior
observed in response to various pruritogens in the PLC3-
deficient mice likely reflects the fact that different mechanisms
underlie the generation of itch and pain in response to noxious
stimulation.
PLC3 Is Required for the Induction of Scratching in Response to
Some, but Not All Pruritogens. We reported that PLC3 contrib-
utes to the itch produced by histamine and its related chemical
compounds (9). Here, we asked how general is the contribution
of PLC3 signaling to the itch that is produced by a variety of
pruritogens. To this end, we tested the effects of 8 different
pruritic compounds in PLC3-deficient mice and in their wild-
type littermates. Each pruritic compound was injected s.c. into
the skin of the nape of the neck and we recorded the resultant
scratching responses over the next 30 min (Fig. 2A). Generally,
hindpaw scratching was directed toward the injection site after
a lag time of several minutes. The scratching peaked between 5
to 10 min.
Among the various pruritogens tested, 5-HT and the selective
agonist, -Me-5-HT, which targets 5-HT2 receptors, evoked
Fig. 1. Temperature, mechanical, and pain behavioral analysis in PLC3-deficient mice and their littermate controls. (A) Latency to exhibit evidence of
discomfort (paw shaking and licking) on a hot plate (n  8 per genotype). (B) Latency to tail withdrawal from a hot or cold water bath (n  6 per genotype).
(C) Percentage of time spent at 30 °C when given a choice between 30 °C and 40 °C (n 4 per genotype). (D) Paw withdrawal frequency to von Frey filaments
(n  8 per genotype). (E) Latency to paw withdrawal from radiant heat before (‘‘0’’) and 2 days after CFA injection (n  8 per genotype). (F) Paw thickness of
the CFA-injected (ipsi) and uninjected (contra) hindpaw (n  8 per genotype). (G) Time spent for paw licking and shaking after formalin injection into a hind
paw during each 5-min interval of a 50-min test period (n  8 per genotype). There were no significant differences at any point between 2 groups (P  0.05,
two-way ANOVA with Bonferroni posttests) for any of the behavioral tests. All data are presented as means  SEM.
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scratching that was almost completely abolished in PLC3-
deficient mice. However, the scratching produced by a variety of
other pruritic agents (including ET-1 and chloroquine) neither
decreased nor increased in the mutant mice (Fig. 2A). This
distinction is further illustrated in Fig. 2 B and C, which show the
time course of scratching during the 30-min test period, at 5-min
intervals after injection of 2 representative pruritogens: -Me-
5-HT, which is a PLC3-dependent pruritogen and ET-1, which
is clearly PLC3-independent. We conclude that PLC3’s con-
tribution as an intracellular itch mediator is highly selective.
Primary sensory neurons express both metabotropic and
ionotropic serotonin receptors (15). The 5-HT3 receptor, a
serotonin gated ion channel receptor, is the dominant isoform
expressed in sensory neurons (16). We asked whether 5-HT or
-Me-5HT elicit scratching by activating the 5-HT3 receptor. In
fact, neither 5-HT- nor -Me-5HT-evoked scratching was al-
tered in 5-HT3 receptor-deficient mice (5-HT: 83.0 41 for WT
and 87.6 38.4 for KO, n 5 per genotype; -Me-5-HT: 154.3
17.2 for WT and 207.0 38.1 for KO mice, n 6 per genotype).
These results are in agreement with the conclusion that seroto-
nin-evoked scratching involves a PLC3-coupled metabotropic
receptor.
The Magnitude of Scratching Responses Correlates with Pruritogen-
Induced Fos Expression in the Dorsal Horn. Among the various
pruritic compounds tested, we chose 2 (-Me-5HT and ET-1) for
further study. These pruritogens differ in their requirement for
PLC3 and show robust scratching in WT mice. The total
number of ‘‘bouts’’ of scratching induced by -Me-5-HT was
approximately double that induced by 5-HT at the same dose.
Based on the dose required to evoke scratching, ET-1 was the
most potent of the pruritogens tested. Thus, most pruritogens,
including the 5-HT related agonists induce scratching at micro-
mole doses, but ET-1 is effective in the picomole range, sug-
gesting that ET-1 acts directly on its cognate receptor to induce
itch.
To test the hypothesis that the magnitude of scratching is
reflected by increased activity of spinal dorsal horn neurons, we
examined Fos induction in upper cervical spinal cord segments.
We studied PLC3-deficient mice and wild-type controls after
s.c. injection of -Me-5-HT or ET-1. Fig. 3 illustrates that both
pruritogens induced a comparable pattern of Fos expression in
the lateral aspect of the superficial dorsal horn (laminae I and
II), and consistent but much less Fos expression in the region of
laminae V and VI (Fig. 3A andC). The mean number of Fos-like
immunoreactive (FLI) neurons induced by ET-1 was approxi-
mately double that recorded after injection of -Me-5HT (Fig.
3 A and C), which is comparable to the relative magnitude of the
scratching induced by these 2 compounds. Furthermore, the
-Me-5-HT- induced FLI was profoundly decreased in the
PLC3-deficient mice, by 75% in laminae I and II and 56% in
laminae V and VI. In contrast, ET-1-induced FLI did not change
in the mutant mice. Again, the persistence of Fos expression
perfectly parallels our finding that ET-1 scratching is not re-
duced in the PLC3-deficient mice. Because the magnitude of
the behavioral phenotype correlated with a marker of activity in
neurons located immediately downstream of the primary affer-
ents, these results indicate that differential activity of the pri-
mary afferent in the mutant and wild-type mice likely accounts
for the differences between -Me-5HT and ET-1 induced
scratching.
PLC3 Mutants Exhibit Deficient Nocifensive Responses to Hindpaw
Injections of Pruritogen. In addition to their scratching responses,
serotonin and ET-1 induce licking of the hindpaw after s.c.
Fig. 2. The scratching elicited by serotonin and -Me-5-HT, but not other
pruritogens, is eliminated in PLC3-deficient mice. (A) The total number of
‘‘bouts’’ of scratching per 30min in response to s.c. injections into the nape of
the neck of 8 different pruritic compounds, in a volumeof 100L. Compounds
tested: 5-HT (100 nmol), -Me-5HT (30 g), ET-1 (10 pmol), chloroquine (200
g), formalin (100 L of 0.6%), U-46619 (3.5 g), SLIGRL-NH2 (100 nmol), and
agmantin (160g). At least 4 andup to 10 pairs of themicewere used for each
compound. (B and C) Time course of scratching after injection of -Me-5HT
and ET-1 in wild-type (filled rectangle) versus PLC3/ (filled circle) mice.
Compared with wild-type mice (n  8), PLC3-deficient mice (n  8) show a
complete abrogation for -Me-5HT but no effect for ET-1. Data represent
means  SEM. Asterisks denote significant differences compared with litter-
mate controls. *, P  0.01, Mann–Whitney U test.
Fig. 3. Fos-like immunoreactivity (FLI) in superficial dorsal horn of the rostral
cervical spinal cord in wild-type and PLC3/ mice after s.c. injection of
-Me-5HT or ET-1 into the nape of the neck. (A–D) There is a dense cluster of
FLI neurons in the lateral part of laminae I and II,whereprimary afferents from
the nape of the neck terminate. ET-1 induced FLI was not altered in the
PCL3/mice comparedwithwild-typemice, but-Me-5-HT-evoked FLIwas
greatly reduced in PCL3/ mice (n  4 to 8 per genotype for each com-
pound). The graphs indicate number of FLI neurons in laminae I, II, V, and VI.
The statistical difference between the 2 genotypes was significant for -Me-
5-HT-evoked FLI (*, P 0.0001, Mann–Whitney U test), but not for ET-1. Error
bars, means  SEM.
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injection into the plantar footpad. This ‘‘nocifensive’’ behavior
has been thought to reflect a pain response (17, 18). Because
PLC3 is dispensable for behavioral responses to noxious ther-
mal and mechanical stimuli, it was of interest to assess whether
PLC3 is required for the licking behavioral responses induced
by pruritogens. We made injections into the glabrous skin of the
hindpaw and monitored the animals’ behavior after injection of
5-HT, -Me-5-HT or ET-1. We used the same amount of
pruritogen as for the nape of the neck and tested the animals
every 10 min for 30 min.
As expected, injection of the pruritogens produces licking
rather than scratching. In wild-typemice, 5-HT, -Me-5-HT, and
ET-1 elicited robust licking of the paw (Fig. 4). In contrast, in
PLC3-deficient mice we found significant deficits in the mag-
nitude of licking produced by injection of either 5-HT or
-Me-5-HT. However, the licking produced by hindpaw injec-
tion of ET-1 was not altered (Fig. 4).
Whether the licking represents a response to a painful or an
itch-producing stimulus or both is unclear and cannot be deter-
mined from our analysis. On the one hand, pruritogens injected
into the hindpaw may evoke a sensation of itch rather than pain,
but licking behavior may occur because mice are not able to
scratch the footpad. However, pruritogens injected into the
hindpaw may evoke a sensation of pain rather than itch, leading
to licking behavior. It is also possible that the different behavior
reflects the type of skin (i.e., hairy vs. glabrous) injected. To
address this question, we next injected the pruritogens subcuta-
neouly into the hairy skin of the thigh. Licking of the thigh is
possible, but scratching is difficult. As for the hindpaw, we found
that PLC3 was required for the licking behavior produced by
-Me-5-HT (Fig. 4). These results indicate that PLC3 is
required for behaviors evoked by injection of 5-HT or -Me-
5-HT (either scratching or licking), and that this requirement is
independent of the region stimulated (hairy vs. glabrous skin).
Whether these different behaviors reflect a common sensation
(itch) producing location-specific behavioral responses, or loca-
tion-specific percepts that evoke sensation-specific behaviors
remains to be determined.
TRPV1-Expressing Primary Afferents Are Essential for the Behavioral
Responses to Both -Me-5-HT and ET-1. As noted above, there is
increasing evidence for a central role of the TRPV1 channel in
itch and pain. To determine how generalized this contribution is,
we examined whether TRPV1 function is also required for the
activity of the pruritic compounds studied in our analyses. As
shown in Fig. 5A, TRPV1-deficient mice showed significant
deficits in histamine induced scratching responses, which is
consistent with a report in ref. 10. In contrast, neither -Me-5-
HT- nor ET-1-evoked scratching was reduced in the mutant
mice, indicating that these pruritogens do not require TRPV1
function. However, these results do not rule out the possibility
that TRPV1-expressing neurons use an alternate signal trans-
ducing mechanism, independent of TRPV1 itself, to respond to
a variety of pruritogens.
To address this question, we used intrathecal injection of
capsaicin to selectively kill the central terminals of TRPV1-
expressing nociceptors and then studied the behavioral conse-
quences (licking) in response to hindpaw injection of different
pruritic compounds. We showed that intrathecal injection of
capsaicin (10 g) kills the central terminals of TRPV1-
expressing neurons but spares DRG cell bodies and the periph-
eral terminals of the TRPV1-positive afferents (33). Fig. 5B
illustrates that compared with vehicle-treated mice, intrathecal
capsaicin-pretreated mice showed greatly reduced licking re-
sponses after hindpaw injection of both -Me-5-HT and ET-1.
The magnitude of licking was reduced by 86 and 75%, respec-
tively in response to the 2 pruritogens (Fig. 5B). Because
hindpaw injection of histamine produced very weak responses
compared with those observed after its injection in the nape of
the neck, we were not able to study the effects of deleting the
TRPV1-expressing nociceptors (Fig. 5B). Nevertheless, based on
our previous observations, it appears that histamine-induced itch
requires both the PLC3 (9) and the TRPV1 gene (10). Thus, we
conclude that TRPV1-expressing neurons carry the input that
drives the behavioral responses to both PLC3-dependent and
-independent pruritogens.
Fig. 4. PLC3-deficient mice show impaired licking behavioral responses to
hindpaw injection of 5-HT (n  4 per genotype) and -Me-5-HT (n  9 per
genotype), but not to ET-1 (n  8 per genotype). Note that the licking
responses produced by thigh injection of -Me-5-HT (n 5 per genotype) are
also significantly impaired in PLC3-deficientmice. *, P 0.05, Student’s t test
for both 5-HT and -Me-5-HT compared with wild-type mice. All data pre-
sented as means  SEM.
Fig. 5. TRPV1 neurons are required for the behavioral responses to different pruritogens. (A) Scratching in response to histamine (n  4 per genotypes),
-Me-5-HT (n 5 per genotypes), and ET-1 (n 4 per genotypes) in TRPV1-mutant mice. In contrast to histamine, scratching in responses to -Me-5-HT and ET-1
was not altered in the mutant mice. *, P 0.05, Student’s t test for histamine comparing the 2 genotypes. (B) Licking in response to histamine, -Me-5-HT, and
ET-1, 1 d after intrathecal capsaicin or vehicle injection. Ablation of the central terminals of TRPV1-expressing neurons led to significant loss of the behavioral
responses to both -Me-5-HT and ET-1. *, P 0.01, two-way rmANOVA followed by Sheffe´’s test; n 3 for capsaicin treated or vehicle-treated). (C) Mice lacking
MrgprD neurons do not show altered scratching behavior in response to 8 different itch-provoking compounds. Data represent means SEM; n 4–8 for all
tests.
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Finally, we investigated whether a major subset of TRPV1-
negative neurons are also implicated in itch. In the mouse,
MrgprD (MrgD)-positive primary afferents account for 90%
of all cutaneous nonpeptidergic neurons and represent60% of
free nerve endings in the skin (19). In particular, MrgprD
neurons in the mouse represent a major subpopulation of
cutaneous C-fiber nociceptors that do not express TRPV1. To
determine whether MrgprD neurons are involved in normal itch,
we used MrgprD cell-ablated mice (MrgprDDTA), in which the
MrgprD locus was replaced with the diphtheria toxin (33),
allowing for the selective elimination of MrgprD-expressing
neurons. Using heterozygous MrgprDDTA mice and their wild-
type littermates, we examined scratching behavior in response to
8 different pruritic compounds (Fig. 5C). Strikingly, we found no
significant differences betweenMrgprDDTA andWTmice, for all
pruritogens tested, indicating that MrgprD-expressing neurons
are not involved in itch. These negative results must be inter-
preted with caution, because there is evidence for functional
compensation when MrgprD neurons are ablated from birth
(33). Nevertheless, the data are consistent with the idea that
TRPV1-expressing neurons are the major, if not exclusive con-
tributors to the sensation of itch produced by a number of
pruritogens.
Discussion
In this study, we selectively ablated 2 nonoverlapping popula-
tions of primary sensory neurons that represent most of the
cutaneous nociceptors and observed that TRPV1-expressing
neurons are required for the behavioral responses to several
different pruritic compounds. We also demonstrated that dif-
ferent pruritic compounds use different intracellular pathways to
induce the scratching reaction, some PLC3-dependent, others
PLC3-independent or both PLC3- and TRPV1-function de-
pendent. Most importantly, we conclude that TRPV1-expressing
neurons have multiple intracellular mechanisms that generate or
mediate itch signals.
A major caveat in these experiments is that our conclusions
depend on different behavioral ‘‘read-outs’’ of the ‘‘itch re-
sponse.’’ One set of experiments relies on licking to stimuli
injected into the hindpaw and the other to scratching in response
to ligands injected in the nape of the neck. Licking is generally
thought to be a behavioral response generated only by painful
noxious stimuli. For example, it is the most pronounced behavior
produced by injection of the algogen, capsaicin. However, the
characteristics of the licking produced by capsaicin differ from
those seen with the pruritic compounds, -Me-5HT and ET-1.
Licking begins immediately after capsaicin injection, and is
completed within 5–10 min. Another painful stimulus, bradyki-
nin (BK) also induces only a brief bout of licking immediately
after its injection (20). In contrast, ET-1- or -Me-5-HT-induced
licking is prolonged, lasting from 20 to 30 min, which is similar
to the time course observed when scratching is induced. Thus,
licking resulting from these compounds may predominantly
reflect an itch-associated response, rather than a response to a
painful stimulus. Our preliminary results using a behavioral
‘‘cheek-pouch’’ assay (21), which reportedly distinguishes itch
and pain responses, also showed that there are no obvious pain
behaviors after injection of -Me-5-HT. This is consistent with
our conclusion that -Me-5-HT is a pure itch-evoking compound
in the mouse.
TheMolecular Specificity of Gq-PLC Intracellular Signaling and Itch.
We identified PLC3 as a critical intracellular mediator in
C-fiber nociceptors that link the histamine H1 receptor to
histamine-evoked itch. Here, we show that PLC3 also mediates
serotonin-evoked itch. In fact, PLC3-deficient mice exhibit an
almost complete loss of serotonin- or -Me-5-HT-induced
scratching. By contrast, the PLC3-deficient mutant mice re-
spond normally to ET-1, SLIGRL-NH2 (a protease-activated
receptor 2 agonist) and U-46619 (a thromboxane A2 receptor
agonist), despite the fact that the cognate receptors correspond-
ing to these ligands also signal via Gq-PLC (22–24). There-
fore, we conclude that Gq-coupled pruritic compounds elicit an
itch response through at least 2 different Gq pathways: one is
PLC3-dependent and the other is PLC3-independent.
In our study (9), we found that PLC3 is necessary for
histamine induced cellular responses, whereas in the same
neuron, the responses to bradykinin, a ‘‘painful’’ stimulus, were
independent of PLC3. Here, we find that PLC3 is not required
for the behavioral responses in various tests of mechanosensa-
tion, temperature responsiveness, and pain. Thus, the PLC3-
dependent pathway is dedicated to signal itch in response to
specific pruritogens, including histamine and serotonin, but this
pathway does not contribute to noxious stimulus-evoked pain.
Multiple Mechanisms of Pruritic Signaling in TRPV1-Expressing Neu-
rons. The results after intrathecal capsaicin-induced destruction
of the TRPV1-expressing neurons indicate that both PLC3-
dependent and -independent itch responses occur within the
population of TRPV1-expressing neurons. It follows that
TRPV1-expressing neurons are heterogenous with respect to the
expression of PLC3. In fact, double immunolabeling experi-
ments in DRG neurons with TRPV1 and PLC3 antibodies
indicate that only 35% (160/458) of TRPV1 neurons express
PLC3 (Fig. S1). It is likely, therefore, that -Me-5-HT exerts its
itch producing effects via the activity of PLC3TRPV1
neurons. By contrast, our observation that ET-1-evoked itch
requires TRPV1 neurons, but does not require PLC3 or
TRPV1 protein indicates that the itch evoked by ET-1 is
generated by a different mechanism from that which mediates
the response to serotonin (Fig. 6), even though TRPV1-
expressing neurons are involved. However, histamine-induced
itch appears to require both PLC3 and TRPV1, which suggests
that TRPV1 can function as an effector molecule downstream of
PLC3. In support of this proposal, a recent electrophysiological
study (25) demonstrated that TRPV1 is directly activated by
diacylglycerol (DAG), which is produced by hydrolysis of PIP2,
a substrate of PLC3. There may be other mechanisms as well
for TRPV1 activation in histamine-mediated signaling (10).
Finally, although there was no diminution of serotonin or ET-1
evoked scratching in TRPV1-mutant mice, ablation of the
TRPV1-expressing neurons markedly decreased the behavioral
response to these compounds. The difference must reflect the
functional differences between deleting the TRPV1 channel and
eliminating the TRPV1-expressing afferents.
Fig. 6. This schematic illustrates 3 distinct and likely independent pathways
through which itch can be induced by a histamine, -Me-5-HT or ET-1 action
upon TRPV1-expressing neurons.
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The existence of multiple subsets of neurons responding to
itch-provoking stimuli is supported by recent reports that hista-
mine- and cowhage-induced itch involve different sensory cir-
cuits (26–29). Histamine-induced calcium responses were ob-
served in 23% of IB and 7% of the IB4 neurons (9). Moreover,
our results suggest that histamine, serotonin, and ET-1 generate
itch signals by activating TRPV1 neurons through at least 3
different intracellular signal transducing pathways (Fig. 6). The
disposition of these molecular signal transducing pathways
among the TRPV1 neurons is, however, unclear.Whether these
subsets correspond to nonoverlapping populations of TRPV1-
expressing neurons remains to be determined.
Materials and Methods
Mice. Two- to three-month-old PLC3-deficient and MrgprdDTA mice (back-
cross-ed to C57BL/6J) were used. Two-month-old male C57BL/6J mice were
purchased from Charles River Laboratories. HTR3a receptor-deficient and
TRPV1-mutant mice were purchased from The Jackson Laboratory. The mice
for behavioral testing were obtained by mating heterozygous animals. All
experiments were approved by the Institutional Animal care and Use Com-
mittees and conducted in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Behavioral Studies. PLC3/, HTR3a/ TRPV1/, MrgprDDTA, and their
wild-type littermate controls were individually housed at least 3 days before
testing, which was performed blind to genotype and to the particular chem-
ical compounds injected. Hot plate, tail immersion, temperature preference
assay, CFA-induced inflammation, and formalin tests were carried out as
described (30–32). See SI Text for a detailed description of the behavioral
methods.
Intrathecal Injection.Micewere anesthetizedwith 1.5% isoflurane before and
for 30min after intrathecal (i.t.) injectionof capsaicin (10g; Sigma) or vehicle
(10%ethanol and 10%Tween-80 in saline) in a volumeof 5.0L. The injection
was made at the level of the pelvic girdle with a luer-tipped Hamilton syringe
to which a 30-gauge needle was attached.
Histology. Fos immunohistochemistry and its quantification were performed
as described in SI Text.
Data Analysis. Data are expressed as the mean  SE. Statistical comparisons
weremadeusing Student’s t test, two-wayANOVAwith Bonferroni post tests,
Mann–WhitneyU test, or two-way rmANOVA followedby Sheffe´’s test.When
the P value was 0.05, the difference was considered to be significant.
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